$PULM -- been an absolute stinker -- concurrent small offerings and R/S then direct offering but w/ equiv warrants; institutions effectively acquired 35-40% of the company for $2.5M on Friday.
On watch for executive options being filed at this price; and then the start of PUR1900 trial, seemingly with some sort of external funding news.
All comments are solely my opinion. Please formulate your own opinion and act on your own accord on all actions you take.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.